Detailed Narrative
Clinical Staffing and Retention Improvements
Encompass Health reported significant improvements in clinical staff retention, achieving its lowest annualized RN turnover rate since at least 2012 at 17.8% in Q1 FY26, down from 20.2% in FY25. Annualized therapist turnover also decreased to 6.4% from 7.8% last year. These positive trends are attributed to professional growth and development programs, such as clinical ladders, with 35% of the nursing staff now participating. The company's centralized talent acquisition team and local hospital focus on retention have contributed to a 9.4% decline in premium labor spend compared to Q1 2025.
Capacity Expansion and Occupancy Management
The company is actively investing in capacity to meet strong demand for inpatient rehabilitation services. In Q1, a new 49-bed hospital was opened, and 44 beds were added to existing facilities. Plans for the remainder of 2026 include opening 7 more hospitals (totaling 340 beds) and adding an incremental 100 to 150 beds to existing hospitals. With Q1 average occupancy at 78.7% and 35% of hospitals exceeding 90% occupancy, management has lowered its internal threshold for initiating expansion projects to 70-75% to proactively address constraints. The development of small-format hospitals, with at least one expected in 2027, will further complement existing de novo and bed expansion strategies.
Medicare Advantage (MA) Trends and Strategy
Medicare Advantage penetration appears to have peaked nationwide at approximately 52% and is now slightly receding, impacting 31% of Encompass Health's home counties. While MA patients tend to be of higher acuity, the company is implementing an "admit and appeal" strategy in 9 hospitals for initially denied MA claims, showing early positive results in approval rates. Management believes that the large and growing population of Medicare fee-for-service patients, projected to reach 35 million non-MA beneficiaries by 2030, represents a significant underserved market opportunity.
Regulatory Environment and Proposed Rule
Encompass Health is navigating a busy regulatory landscape, including the implementation of TEAM on January 1 and the expansion of RCD into Texas and California. The 2027 IRF proposed rule, released on April 2, includes a net market basket update of 2.4%, which is estimated to result in a 2.4% pricing increase for Medicare patients beginning October 1, 2026. The company plans to provide comments on the proposed rule and remains actively engaged in discussions with policymakers to ensure understanding of the value proposition of inpatient rehabilitation.
Capital Allocation and Free Cash Flow Utilization
Q1 adjusted free cash flow was $194 million, with the primary use continuing to be capacity expansions. The company repurchased 708,000 shares of common stock for $71.6 million and paid a $0.19 per share cash dividend. Net leverage stood at 1.9x at quarter-end. For FY26, after accounting for growth CapEx of $725 million and dividends of $77 million, approximately $56 million in cash is expected to be available for other uses, with additional capacity for share buybacks if leverage is increased up to 2x, suggesting at least $140 million remaining for buybacks after Q1.